NCCN-protocol care · 96.9% 1-yr breast cancer survival · ArogyaSri, CGHS & cashless insurance accepted · Free second opinion
1800 202 8726
Treatment Decision Guide · Reviewed by CION Oncologists · NABH Accredited

Surgery or Chemoradiation for Early Cervical Cancer — How the Choice Is Made

For cervical cancer that is still confined to the cervix, there are two ways to attempt a cure: radical surgery, or chemoradiation — radiation to the pelvis given alongside chemotherapy and finished with brachytherapy. Randomised evidence has shown that, for suitable early-stage tumours, the two give comparable survival. So the decision is not about which one works better. It is about tumour size, lymph node status, your age, whether you want children, whether your ovaries can be preserved, and which set of long-term side effects fits your life. This page explains how a tumour board actually reaches that decision.

  • Comparable cure rates in early disease — the choice turns on side effects and circumstances, not on survival
  • One modality, not two — the whole aim of good planning is to avoid needing surgery and radiation
  • Beyond early stage there is no choice — locally advanced disease is treated with chemoradiation, per NCCN and ESMO
  • Every plan agreed at a tumour board — surgical, radiation and medical oncology together, across 7 NABH-accredited locations
4.8 · 1,000+ Google reviews · 15,000+ patients treated
Same-Week Appointments

Discuss Your Treatment Options

₹950   Today: FREE  ·  Consultation with a woman doctor on request

Surgical and radiation oncology opinion in one visit
Fertility and ovarian preservation discussed before you decide
Confidential. No commitment to start treatment.
or
Call 18002028726
17+
Cancer Specialists
on Panel
96.9%
Breast Cancer
Survival Rate*
15,000+
Patients
Treated
4.8★
Google Rating
(800+ reviews)

First, Who Actually Has a Choice?

The question “surgery or radiation?” only has two answers for a specific group of women. Stage decides that, and stage is assigned under the FIGO system after examination, pelvic MRI and, where indicated, PET-CT.

  • Very early, microscopic disease — found only under the microscope after a cone biopsy. Surgery is usually all that is needed, and in some cases the cone biopsy itself has already removed the cancer.
  • Early disease confined to the cervix, tumour under about 4 cm — this is where the genuine choice lies. Radical surgery and chemoradiation are both curative options with comparable survival. Read what this stage means on our stage 1 cervical cancer page.
  • Bulky tumours of 4 cm or more, or disease extending beyond the cervix — chemoradiation followed by brachytherapy is the standard of care. Surgery here would very likely be followed by radiation anyway, which is the one outcome good planning tries to avoid.
  • Disease that has spread to distant organs — the plan becomes systemic rather than local. See treating advanced cervical cancer.

If you are still working out what your diagnosis means before thinking about treatment, start with the cervical cancer overview. If you already have a stage written on your report, this page is written for you.

Did You Know? Overall treatment time matters in cervical cancer. NCCN and ESMO guidance both stress that a curative course of chemoradiation, including brachytherapy, should be completed within about eight weeks, because unplanned gaps and prolonged schedules are associated with poorer local control. That is one reason treatment breaks are managed so carefully, and why a centre that can deliver brachytherapy without a waiting list matters more than it might appear. Sources: NCCN Guidelines for Cervical Cancer; ESMO Clinical Practice Guidelines for Cervical Cancer.

The Principle Behind the Decision: One Treatment, Not Two

If there is a single idea to take away from this page, it is this. Surgery and radiation each carry their own set of long-term effects. A woman who has both carries both sets — and the combination causes considerably more bladder, bowel and lymphatic problems than either alone. So the aim of the tumour board is not simply to pick the treatment most likely to cure. It is to pick the treatment most likely to cure without needing the other one afterwards.

That is why staging is done so thoroughly before anything starts. If the MRI shows a tumour large enough that the pathology after surgery would almost certainly trigger radiation — because of tumour size, deep invasion of the cervical wall, spread into lymphatic channels, involved margins, parametrial extension or positive lymph nodes — then the sensible plan is chemoradiation from the outset. NCCN sets out recognised intermediate-risk and high-risk pathology criteria that determine when radiation must follow surgery, and an experienced team predicts those before the operation rather than discovering them after it.

The same logic works in reverse. A small tumour in a fit younger woman who wants her ovaries preserved is a strong argument for surgery, because the probability of needing radiation afterwards is low, and surgery leaves her ovarian function intact in a way pelvic radiation cannot. Understanding the side effects of pelvic radiation and the different types of hysterectomy used for cervical cancer is what makes that conversation a real choice rather than a formality.

What Each Treatment Actually Involves

Two paths, two very different rhythms. Here is what each one asks of you.

The surgical path

A radical hysterectomy removes the uterus, the cervix, the supporting tissue on either side of the cervix and a cuff of the upper vagina, together with an assessment of the pelvic lymph nodes — either by sentinel node mapping or by a formal pelvic lymph node dissection. For carefully selected low-risk tumours, current evidence supports less radical surgery. It is one operation, a few days in hospital, and a graded return to normal activity over roughly six to eight weeks — described in detail on our recovery after a hysterectomy page. Its great advantage is information: the pathology tells you exactly what was there. Its main costs are bladder function that can take time to return, a risk of leg lymphoedema after node surgery, and a shortened vagina.

The chemoradiation path

External beam radiotherapy to the pelvis, given every weekday for around five weeks, with platinum-based chemotherapy once a week alongside it to make the radiation work better. The course is then completed with brachytherapy, where the radiation source is placed directly against the cervix — the part of the treatment that delivers the highest dose exactly where it is needed, and the part that must not be omitted. There is no operation and no anaesthetic, but there is a daily commitment for over a month, chemotherapy side effects to manage each week, and permanent loss of ovarian function unless the ovaries are surgically moved out of the radiation field beforehand.

A question to ask at your first appointment: “Based on my MRI, how likely is it that I will need radiation after surgery?” That single question gets to the heart of the decision. If the answer is “quite likely”, the case for going straight to chemoradiation is strong. If the answer is “unlikely”, surgery becomes far more attractive — particularly if preserving ovarian function matters to you.

Get Both Opinions Before You Decide

Tell us your stage and what has been recommended, and CION will arrange for a surgical oncologist and a radiation oncologist to review your case together, so you hear both sides of the decision. No charge, no obligation.

or
Call 18002028726

By submitting, you consent to be contacted by CION about your enquiry.

12+ Centres in Hyderabad · Pick yours

CION cancer care is closer than you think.

We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.

Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.

Help me pick the right centre
Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Mohammed Imran
Interventional Radiologist

Dr. Mohammed Imran

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

A Treatment Decision Deserves a Team, Not a Single Voice

At CION every cervical cancer plan is agreed at a multidisciplinary tumour board before it is offered to you — surgical, radiation and medical oncology in the same room. Same-week appointments across Hyderabad.

The Factors That Actually Decide It

No single factor decides on its own. This is the weighing-up a tumour board does, factor by factor.

Factor Points towards surgery Points towards chemoradiation
Tumour size Smaller tumours confined to the cervix Bulky tumours of about 4 cm or more
Extension beyond the cervix None on MRI Parametrial, vaginal or pelvic sidewall involvement
Lymph nodes Negative on imaging Suspicious or confirmed positive nodes
Age and ovarian function Younger women — ovaries can often be preserved Post-menopausal, or ovarian preservation not a priority
Fertility Fertility-sparing surgery is possible in selected small tumours Radiation ends fertility; egg or embryo preservation must be arranged first
Fitness for major surgery Good general health, acceptable anaesthetic risk Significant heart, lung or other medical problems
Practical logistics One admission, then recovery at home Daily travel to the centre for around five weeks, plus brachytherapy sessions
Sexual function afterwards Shortened vagina, but tissue remains supple Vaginal narrowing and dryness — manageable, but needs active aftercare

The last row is the one most often left out of the conversation and the one women most often wish they had been told about. Read it properly on our page about the sexual side effects of pelvic radiation before you decide.

Book a Tumour Board Review of Your Case

Bring your MRI, PET-CT and biopsy report. Your case is discussed by surgical, radiation and medical oncology together, and you leave with the recommendation in writing. Free first consultation.

or
Call 18002028726

When the Question Is Not Surgery vs Chemoradiation

For a large number of women the decision described above never arises, because the disease is at a stage where one path is clearly correct. It is worth knowing where you sit.

Locally advanced disease

Once the tumour is bulky or has extended beyond the cervix, chemoradiation with brachytherapy is the treatment, and surgery is not an equivalent alternative. This is settled ground in NCCN and ESMO guidance. The decisions that remain are about the radiation technique, the chemotherapy schedule, and how the brachytherapy is planned.

Disease that has spread beyond the pelvis

Here the plan is systemic. Chemotherapy is combined with an antibody that blocks the tumour's blood supply, and, where testing supports it, with an immunotherapy that targets the PD-1 checkpoint. PD-L1 testing on the tumour helps decide who benefits. Targeted therapy has a defined role in this setting, and a clinical trial is always worth asking about.

Cancer that has come back

The plan for recurrent cervical cancer depends almost entirely on what was given the first time. A recurrence in a pelvis that has already been irradiated is a different problem from one in a pelvis that has not, and in a small number of carefully selected women a pelvic exenteration can still be curative. These decisions belong in a multidisciplinary meeting, not in a single clinic room.

Whatever your situation, the drug schedules, radiation techniques, package costs and insurance details for cervical cancer care in Hyderabad are set out on our cervical cancer treatment in Hyderabad page.

Did You Know? The surgical approach itself changed on the strength of a randomised trial. Minimally invasive radical hysterectomy was widely adopted for cervical cancer until randomised evidence showed worse disease-free and overall survival compared with open surgery. NCCN guidance now identifies the open abdominal approach as the standard for radical hysterectomy in cervical cancer. It is a fair and reasonable question to ask any surgeon which approach they intend to use, and why. Source: NCCN Guidelines for Cervical Cancer.

Why Women in Hyderabad Bring This Decision to CION

A choice between two curative treatments should be made by a team that can deliver both of them well.

Both modalities under one roof

Surgical and radiation oncology in the same institution, so neither option is favoured by default

Tumour board for every treatment plan

Surgery, radiation and medical oncology agree the plan together — per NCCN, FIGO and ESMO

Brachytherapy delivered without delay

The part of chemoradiation that most affects cure — and the part most often postponed elsewhere

Fertility and ovarian preservation raised early

Discussed before treatment starts, when the options are still open

1-year survival: 83.3% at CION

For cervical cancer, against a national figure of 67.3% — CION outcomes data

17 oncologists across specialties

Medical, surgical and radiation oncology, with 45-minute consultations

Woman doctor available on request

At every location, with a female attendant present for every examination

7 NABH-accredited Hyderabad locations

Kukatpally, Kompally, Ameerpet, Tolichowki, MasabTank, L.B. Nagar, Banjara Hills

EMI facility & insurance accepted

All major TPAs · Aarogyasri, CGHS, ECHS & ESI for eligible patients

Take The Next Step

Understand Both Options Before You Commit to One

You are allowed to ask why one treatment was recommended over the other, and you are allowed to hear the answer from both specialties. That conversation takes one appointment.

Real Stories. Real Voices.

15,000+ patients chose CION. Hear from them directly.

These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.

4.8★800+ Google reviews
50+video testimonials
15,000+patients treated

Successful Chemotherapy Done by Dr. C Raghavendra Reddy

Watch video →

Surgery, Chemo & Radiation Done by Dr. Imaduddin, Dr. Vinay, Dr. Owais, Dr. Kirti

Watch video →

Successful Radical Thymectomy Done by Dr. Mohammed Imaduddin & Dr. Vinay Mamidala

Watch video →

Successful Surgery Done by Dr. Rajender Byshetty

Watch video →

Successful Chemo & Surgery Done by Dr. Imad, Dr. Vinay, Dr. Owais & Dr. Raghavendra

Watch video →

Successful Chemo & Surgery Done by Dr. Imad, Dr. Vinay, Dr. Owais & Dr. Raghavendra

Watch video →

Successful Chemo & Radiation Done by Dr. Owais Mohammed & Dr. Kirti Ranjan Mohanty

Watch video →

Successful Breast Cancer Surgery Done by Dr. Imaduddin Mohammed & Dr. Vinay Mamidala

Watch video →

Successful Chemotherapy Done by Dr. Bharati Devi Gorantla

Watch video →

Successful Chemo & Surgery Done by Dr. Owais Mohammed & Dr. Imaduddin Mohammed

Watch video →

Successful Chemotherapy Done by Dr. Gundu Naresh

Watch video →

Successful Bone Marrow Transplantation - Neuroblastoma

Watch video →

Successful Surgery & Chemo - Carcinoma of Caecum

Watch video →

Successful Oral chemotherapy & mastectomy surgery

Watch video →

Successful Oral chemotherapy & mastectomy surgery

Watch video →

Successful Chemotherapy

Watch video →

Successful Surgery by Dr. Mohammed Imaduddin

Watch video →

Successful Bone Marrow Transplantation

Watch video →

Successful Oral chemotherapy & mastectomy surgery

Watch video →

Successful Oral chemotherapy & mastectomy surgery

Watch video →

Successful Chemotherapy

Watch video →

Successful Buccal Mucosa Surgery

Watch video →

Successful Complex Surgery Mandibulectomy Reconstruction

Watch video →
Common questions

Surgery or Chemoradiation — Frequently Asked Questions

Is surgery better than radiation for early cervical cancer?

For early-stage disease confined to the cervix, randomised evidence has shown that radical surgery and definitive chemoradiation produce comparable survival. Neither is simply "better". They differ in what they ask of you and in what they leave behind: surgery is a single operation with a recovery period and gives full pathology information, while chemoradiation avoids an anaesthetic but requires daily attendance for around five weeks and ends ovarian function unless the ovaries are moved beforehand. The right answer for an individual woman depends on tumour size, node status, age, fertility wishes and fitness for surgery, which is why the decision belongs at a tumour board.

Why do doctors try to avoid giving both surgery and radiation?

Because each treatment has its own long-term effects on the bladder, bowel and lymphatic drainage of the pelvis, and having both increases those effects considerably more than having either alone. Careful staging with MRI and, where indicated, PET-CT is done precisely to predict whether the pathology after surgery would trigger radiation anyway. If it almost certainly would — because of tumour size, deep invasion, involved margins, parametrial spread or positive lymph nodes — then going straight to chemoradiation spares you one full set of side effects without reducing your chance of cure.

How long does each treatment take from start to finish?

Surgery is concentrated: an operation, a hospital stay of a few days, and a graded return to normal activity over roughly six to eight weeks, with the pathology result available in one to two weeks. Chemoradiation is spread out: external radiation on weekdays for about five weeks with weekly chemotherapy alongside it, then a small number of brachytherapy sessions to complete the course. Guidance recommends finishing the whole radiation course within about eight weeks, so unplanned gaps are avoided wherever possible. Plan for daily travel to the centre during the external radiation phase.

Will I go through menopause after treatment for cervical cancer?

It depends on which treatment you have and on your age. A hysterectomy alone does not cause menopause if the ovaries are left in place, and in younger women with cervical cancer the ovaries can often be preserved. Pelvic radiation does end ovarian function permanently, because the ovaries sit within the treatment field — unless they are surgically moved out of that field beforehand, an option worth asking about if you are pre-menopausal. If menopause does follow treatment, symptoms can be managed, and hormone replacement is appropriate for many women after cervical cancer. Raise this before treatment starts.

Can I choose which treatment I have, or is it decided for me?

Where both options are genuinely curative, your preference is a legitimate and important part of the decision, and a good team will present both honestly rather than steering you. Where the stage makes one option clearly correct — a bulky tumour, spread beyond the cervix, or involved lymph nodes — offering a free choice would not be honest, and the recommendation will be chemoradiation. Ask directly whether you are in the group where both are reasonable. You are also entitled to a second opinion, which at CION is free and includes a review by both surgical and radiation oncology.

Medical disclaimer: This page is general health information, reviewed by a CION oncologist. It describes how treatment decisions are made in general and cannot replace a plan built around your own stage, scans and pathology. Do not start, stop or change any cancer treatment on the basis of a website.

Explore more

Explore All Cervical Cancer Topics

Browse our complete library of cervical cancer guides — covering symptoms, HPV, vaccination, screening, abnormal results and precancer, diagnosis and staging, treatment, fertility, survival, survivorship and cost in Hyderabad.

Call now Book free consultation